ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹23 Cr | ₹20 Cr | ₹26 Cr | ₹32 Cr | ₹34 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹23 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹26 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹34 Cr |
How is Deferred Tax Assets / Liabilities of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹23 Cr | 16.96 | |
| Mar2024 | ₹20 Cr | -22.57 | |
| Mar2023 | ₹26 Cr | -18.68 | |
| Mar2022 | ₹32 Cr | -6.33 | |
| Mar2021 | ₹34 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,509.2 Cr | 5.3% | 14.8% | -1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,613.0 Cr | 1.5% | 5.5% | 0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,105.0 Cr | 2.3% | 3.6% | 7.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,926.0 Cr | -0.5% | 5.3% | 40.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,088.0 Cr | 0.9% | 5.2% | 7% | Stock Analytics | |
| CIPLA | ₹107,120.0 Cr | -1.1% | -2.2% | -8.9% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 5.3% |
14.8% |
-1.2% |
| SENSEX | 0% |
1.2% |
9.7% |
You may also like the below Video Courses